India's #1 Financial News | Nifty 50 Live, Sensex Today, Bitcoin Price INR, Gold Rate, Stock Market & Crypto Analysis by Expert Team
India's #1 Financial News | Nifty 50 Live, Sensex Today, Bitcoin Price INR, Gold Rate, Stock Market & Crypto Analysis by Expert Team
#SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading #SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading
No related posts.
Raj Gaurav Rai is the founder and chief editor of EarnFree.in with 10+ years of experience in Indian equity markets, technical analysis, Nifty 50, Bank Nifty F&O trading, cryptocurrency and financial journalism. He actively trades NSE/BSE equities and crypto markets, ensuring all analysis is grounded in real market experience. Based in Varanasi, Uttar Pradesh, India.
